P4Z-82339-66918 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-13
Dose 1 — Pfizer-BioNTech
2021-03-06
Dose 2 — Pfizer-BioNTech
2021-10-29
Dose 3 — Pfizer-BioNTech
2021-10-30
Registered in v-safe
2021-10-30
Survey response — days 1–6 daily, dose 3
MedDRA: Pregnancy — Feeling: Fair · Fever · Chills, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: 18 weeks pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-10-31
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Abdominal pain

Adult check-in
2021-11-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-05
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-12
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-13	Pfizer-BioNTech	No
2	2021-03-06	Pfizer-BioNTech	No
3	2021-10-29	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-30

Systemic reaction (other): 18 weeks pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release